| A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion (NCT01308541) | Eisai Inc. | 2011-01-01 |
| Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy Subjects (NCT01074593) | Azidus Brasil | 2011-01-01 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PLX5622 in Healthy Adult Volunteers (NCT01282684) | Plexxikon | 2011-01-01 |
| Metronidazole Pharmacokinetics (PK) in Premature Infants (NCT01222585) | Michael Cohen-Wolkowiez | 2011-01-01 |
| Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut (NCT01275508) | University of Erlangen-Nürnberg Medical School | 2011-01-01 |
| Preventing Myocardial Ischemia by Preconditioning in Elective Operation for Abdominal Aortic Aneurysm (NCT01523262) | Aarhus University Hospital | 2011-01-01 |
| Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML (NCT01277484) | Seoul St. Mary's Hospital | 2011-01-01 |
| Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma (NCT01245556) | Bristol-Myers Squibb | 2011-01-01 |
| Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia (NCT01251809) | medac GmbH | 2011-01-01 |
| Renal Artery Denervation in Chronic Heart Failure (NCT01584700) | Imperial College London | 2011-01-01 |
| Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma (NCT01264731) | University of Virginia | 2011-01-01 |
| Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer (NCT01407107) | University of Texas Southwestern Medical Center | 2011-01-01 |
| Intravenous Norepinephrine for Orthostatic Hypotension (NCT01285908) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-01-01 |
| Study on the Safety of Abatacept in Relapsing Polychondritis (NCT01272856) | Benaroya Research Institute | 2011-01-01 |
| Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) (NCT01316185) | Eiger BioPharmaceuticals | 2011-01-01 |
| Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury (NCT01251003) | Charles Cox | 2011-01-01 |
| GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy (NCT01274182) | Sandoz | 2011-01-01 |
| Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation (NCT01967953) | Policlinico Hospital | 2011-01-01 |
| A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab (NCT01285466) | Novartis Pharmaceuticals | 2011-01-01 |
| Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer (NCT01279291) | Kyowa Kirin Co., Ltd. | 2011-01-01 |
| A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma (NCT01264380) | Hoffmann-La Roche | 2011-01-01 |
| Systemic Fluoride Bioavailability From Toothpastes Containing Calcium Carbonate or Silica as Abrasives (NCT01571050) | University of Campinas, Brazil | 2011-01-01 |
| DDI Between BI Empagliflozin (10773) and Verapamil (NCT01276301) | Boehringer Ingelheim | 2011-01-01 |
| Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema (NCT01194674) | National Institutes of Health Clinical Center (CC) | 2011-01-01 |
| Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma (NCT01240005) | Qingdao University | 2011-01-01 |
| Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting Condition (NCT01694797) | Dr. Reddy's Laboratories Limited | 2011-01-01 |
| A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK2248761 Administered as an Oral Suspension to Healthy Adult Subjects (NCT01273103) | ViiV Healthcare | 2011-01-01 |
| Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. (NCT00890500) | Fate Therapeutics | 2011-01-01 |
| Safety Study of Latanoprost Slow Release Insert (NCT01180062) | Daniel Moore | 2011-01-01 |
| Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas (NCT01279603) | Genus Oncology, LLC | 2011-01-01 |
| MSC and MC in Type 2 Diabetes Mellitus (NCT01719640) | Fuzhou General Hospital | 2011-01-01 |
| AZD2115 Single Ascending Dose Study (NCT01283984) | AstraZeneca | 2011-01-01 |
| Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy Children (NCT01273246) | Sinovac Biotech Co., Ltd | 2011-01-01 |
| Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer (NCT01288261) | University of Arizona | 2011-01-01 |
| A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer (NCT01304784) | Merrimack Pharmaceuticals | 2011-01-01 |
| Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects (NCT01272206) | Novo Nordisk A/S | 2011-01-01 |
| MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease (NCT01522118) | University of Roma La Sapienza | 2011-01-01 |
| Feel Breathe, Restriction Device Ventilatory Nasal (NCT01608529) | University of Cadiz | 2011-01-01 |
| Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases (NCT01309048) | Philips Healthcare | 2011-01-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects (NCT01297582) | Ono Pharma USA Inc | 2011-01-01 |
| Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet (NCT01256151) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-01-01 |
| METHOD - Bone Marrow Derived Mononuclear Cells in Chronic Ischemic Disease (NCT01666132) | Cardiocentro Ticino | 2011-01-01 |
| Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) (NCT01218477) | Bristol-Myers Squibb | 2011-01-01 |
| A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy (NCT01297998) | Kansai Hepatobiliary Oncology Group | 2011-01-01 |
| Study to Determine if Fibrin Affects the Ability of a Wound to Heal (NCT01253135) | Healthpoint | 2011-01-01 |
| CKD-828 (40/5mg) Pharmacokinetic Study (NCT01340131) | Chong Kun Dang Pharmaceutical | 2011-01-01 |
| A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of Mipomersen in Japanese Healthy Volunteers (NCT01299298) | Kastle Therapeutics, LLC | 2011-01-01 |
| TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation (NCT01300611) | Tarix Pharmaceuticals | 2011-01-01 |
| A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects (NCT01591148) | Stanford University | 2011-01-01 |
| A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption (NCT01366287) | Pfizer | 2011-01-01 |
| Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer (NCT01264705) | University of Texas Southwestern Medical Center | 2011-01-01 |
| Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes (NCT01305135) | Groupe Francophone des Myelodysplasies | 2010-12-30 |
| A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. (NCT01466322) | GlaxoSmithKline | 2010-12-22 |
| A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma. (NCT01237236) | Novartis Pharmaceuticals | 2010-12-21 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients (NCT02675803) | Novartis Pharmaceuticals | 2010-12-20 |
| Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration (NCT01271270) | National Eye Institute (NEI) | 2010-12-20 |
| A Study to Evaluate the Bioequivalence of Over-encapsulated Oseltamivir Capsules to Marketed Oseltamivir Capsules in Healthy Volunteers (NCT01258530) | GlaxoSmithKline | 2010-12-20 |
| A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer (NCT01268059) | MedImmune LLC | 2010-12-16 |
| A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer (NCT01281514) | Fox Chase Cancer Center | 2010-12-14 |
| A Study of AMG 337 in Subjects With Advanced Solid Tumors (NCT01253707) | Amgen | 2010-12-08 |
| Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg (NCT01271998) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2010-12-08 |
| Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas (NCT01143545) | National Cancer Institute (NCI) | 2010-12-07 |
| Bioequivalence Trial of Alprazolam 0.5 mg Tablets (NCT01745562) | GlaxoSmithKline | 2010-12-07 |
| Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression (NCT01256554) | M.D. Anderson Cancer Center | 2010-12-03 |
| Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors (NCT01259479) | National Cancer Institute (NCI) | 2010-12-03 |
| Phase I Study of Feasibility of Single Session Spine Stereotactic Radiosurgery (SSRS) in the Primary Management in Patients With Inoperable, Previously Unirradiated Metastatic Epidural Spinal Cord Compression (MESCC) (NCT01254903) | M.D. Anderson Cancer Center | 2010-12-03 |
| Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2126458 and GSK1120212 Combination Therapy in Subjects With Advanced Solid Tumors. (NCT01248858) | GlaxoSmithKline | 2010-12-03 |
| Bioequivalence Trial of Alprazolam 0.25 mg Tablets (NCT01853956) | GlaxoSmithKline | 2010-12-02 |
| Study to Evaluate the Effects of TRV120027 in Patients With Heart Failure (NCT01187836) | Trevena Inc. | 2010-12-01 |
| A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza (NCT01033734) | Hoffmann-La Roche | 2010-12-01 |
| A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma (NCT01248923) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2010-12-01 |
| Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT01062399) | Radiation Therapy Oncology Group | 2010-12-01 |
| First-in-Human Single Ascending and Multiple Dose of GLPG0778 (NCT01278108) | Lakefront Biotherapeutics NV | 2010-12-01 |
| Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer (NCT01065441) | Michael Har-Noy | 2010-12-01 |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy (NCT00558675) | Mirror Biologics, Inc. | 2010-12-01 |
| MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes (NCT01273181) | National Cancer Institute (NCI) | 2010-12-01 |
| A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer (NCT01256567) | Eli Lilly and Company | 2010-12-01 |
| A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients (NCT01262235) | Arbutus Biopharma Corporation | 2010-12-01 |
| Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors (NCT02220049) | Gustave Roussy, Cancer Campus, Grand Paris | 2010-12-01 |
| Secretin Infusion for Pain Due to Chronic Pancreatitis (NCT01265875) | ChiRhoClin, Inc. | 2010-12-01 |
| A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 25-mg Tablets Relative to One 50-mg Tablet (NCT01273506) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-12-01 |
| Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects. (NCT01443221) | JW Pharmaceutical | 2010-12-01 |
| Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer (NCT01254526) | Genentech, Inc. | 2010-12-01 |
| Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection) (NCT01253317) | Boston Children's Hospital | 2010-12-01 |
| The Effect of a Meal on Vitamin D Absorption (NCT01268176) | Tufts University | 2010-12-01 |
| Cell Therapy in Limb Girdle Muscular Dystrophy (NCT02245711) | Neurogen Brain and Spine Institute | 2010-12-01 |
| Moxibustion for Knee Osteoarthritis (NCT01354860) | Korea Institute of Oriental Medicine | 2010-12-01 |
| A Study to Assess the Potential Effects of Rifampin on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies (NCT01273480) | Janssen Research & Development, LLC | 2010-12-01 |
| The Use of Methadone in Newborn Infants (NCT01327079) | John van den Anker | 2010-12-01 |
| A Study of Relative Bioavailability and Food Effect Study of Cobimetinib in Healthy Participants (NCT01249131) | Genentech, Inc. | 2010-12-01 |
| Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma (NCT01743157) | California Pacific Medical Center Research Institute | 2010-12-01 |
| A Comparison Of The Pharmacokinetics Of PF-04191834 Following Single Dose Administration Of A Dispersion Formulation And A Suspension Formulation In Healthy Volunteers (NCT01265732) | Pfizer | 2010-12-01 |
| Gene Therapy of Pancreatic Ductal Adenocarcinoma (NCT01274455) | University Hospital, Toulouse | 2010-12-01 |
| Lime Powder Regimen in Healthy Volunteers (NCT01273025) | Chulalongkorn University | 2010-12-01 |
| Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue (NCT01319916) | Kythera Biopharmaceuticals | 2010-12-01 |
| Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma (NCT01208454) | National Cancer Institute (NCI) | 2010-12-01 |
| RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma (NCT01189240) | National Cancer Institute (NCI) | 2010-12-01 |
| Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme (NCT01260506) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2010-12-01 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases (NCT01234740) | City of Hope Medical Center | 2010-12-01 |
| Study of AERAS 422 in Healthy Adults (NCT01340820) | Aeras | 2010-12-01 |